Skip to main content
Sign In
 

Lisa Davis, MD

Assistant Professor of Medicine


​7/2010-6/2012 Post-Doctoral Fellowship, Rheumatology, Division of Rheumatology
                                University of Colorado School of Medicine, Aurora, CO

7/2009-8/2012 MS Clinical Sciences, University of Colorado Graduate School, Aurora, CO

7/2008-6/2010 Fellowship, Rheumatology, Division of Rheumatology, 
                                University of Colorado School of Medicine, Aurora, CO

7/2005-6/2008 Medical Residency, Internal Medicine, Department of Internal Medicine, 
                                University of Colorado School of Medicine, Aurora, CO

8/2001-5/2005   MD, University of Colorado School of Medicine, Denver, CO

8/1994-4/2000 BS Brigham Young University, Major: Molecular Biology (Cum Laude), 
                                Minor: Chemistry , Provo, UT​​
​​
7/2012-present   Associate Program Director, Department of Medicine, University of Colorado                                   School of Medicine, Aurora, CO

7/2012-present   Assistant Professor, Division of Rheumatology, Department of Medicine, 
                                Denver Health and University of Colorado School of Medicine, Aurora, CO

7/2011-6/2012 Instructor/Post-Doctoral Fellow, Division of Rheumatology, Department of 
                                Medicine, Division of Rheumatology, University of Colorado School of 
                                Medicine, Aurora, CO​​
​2008-present Member, American College of Rheumatology

2006-present Member, American College of Physicians

2004-present Member, American Medical Association ​
Professional:
  • Poster selected 2nd Place overall for Scientific Research at Denver Health Poster Competition, June 2-6, 2014
  • Selected to attend Rheumatology Research Workshop, Seattle, WA, June 6-7, 2014
  • Ad hoc reviewer for Clinical and Experimental Rheumatology, 2014-present
  • Ad hoc reviewer for PLOS one, 2014-present
  • Ad hoc reviewer for Rheumatology, 2014-present
  • Ad hoc reviewer for Medical Care, 2014-present
  • Ad hoc reviewer for Scandinavian Journal of Rheumatology, 2014-present
  • Ad hoc reviewer for Arthritis Care & Research, 2013-present

Fellowship/ Residency:
  • Selected to attend Rheumatology Research Workshop, Denver, CO, May 4-5, 2012
  • American College of Rheumatology Distinguished Fellow Award, 8/2011
  • Fellow In Training award for the European Workshop for Rheumatology Research meeting, 4/2011
  • Fellow In Training award for the American College of Rheumatology meeting, 10/2010
  • National Institutes of Health Loan Repayment program, 8/2010
  • Fellow In Training award for the American College of Rheumatology meeting, 10/2009
  • Diabetic Teaching award, 2008

Undergraduate:
  • Graduated Cum Laude from BYU, 2000
  • Phi Kappa Phi Honor Society, 1999-2000
  • BYU Writing Fellows program, 1999-2000
  • Exceptional Laboratory Teaching Assistant award, 1997
  • National Merit Scholar, 1994
Published Manuscripts (peer-reviewed):

1.       Sutherland JB, Tanner LA, Moore JD, et al. Conversion of ferulic acid to 4-vinyl guaiacol by yeasts isolated from frozen concentrated orange juice. Journal of Food Protection 1995;58:1260-2. PMC Journal – In Process.

2.       Castlebury LA, Sutherland JB, Tanner LA, et al. Use of a bioassay to evaluate the toxicity of beauvericin to bacteria. World Journal of Microbiology and Biotechnology 1999;15:131-3. doi: 10.1023/A:1008895421989

3.       Davis L, Larson M, Caplan L. Observational study to determine predictors of rheumatology clinic visit provider contact time. Arthritis Care& Research. 2010;62(11):1650-4.  doi: 10.1002/acr.20281; PMID: 20583104

4.       Caplan L, Davis L, Bright C, Kerr G, Lazaro D, Khan N, Richards J, Johnson D, Cannon G, Reimold A, Mikuls T. Body mass index and the rheumatoid arthritis swollen joint count: an observational study. Arthritis Care & Research 2013;65(1):101-106. doi: 10.1002/acr.21734; PMID: 22623288  

5.       Davis LA, Cannon GW, Pointer LF, Haverhals LM, Wolff RK, Mikuls TR, Remold AM, Kerr GS, Richards JS, Johnson DS, Valuck R, Prochazka A, Caplan L. Cardiovascular events are not associated with MTHFR polymorphisms, but are associated with methotrexate use and traditional risk factors in US veterans with rheumatoid arthritis. The Journal of Rheumatology 2013;40(6):809-17. doi: 10.3899/jrheum.121012; PMID: 23547211

6.       Davis LA, Cannon GW, Reimold AM, Mikuls TR, Mann A, Caplan L. Validation of diagnostic and procedural codes for identification of acute cardiovascular events in US veterans with rheumatoid arthritis. eGEMs 2013;1(3). doi: 10.13063/2327-9214.1023; PMID: 2584858. http://repository.academyhealth.org/egems/vol1/iss3/8

7.       Pittman CB, Davis LA, Zeringue AL, Caplan L, Wehmeier KR, Scherrer JF, Xian H, Cunningham FE, Eisen SA, McDonald JR, Arnold A. Myocardial infarction risk among fracture patients receiving bisphosphonates. Mayo Clinic Proceedings 2014;89(1):43-51. doi: 10.1016/j.mayocp.2013.08.021; PMID: 24388021

8.       Hirsh J, Davis LA, Quinzanos I, Keniston A, Caplan L. Health literacy predicts discrepancies between traditional written rheumatoid arthritis patient assessments and verbally-administered assessments.  J Rheumatol 2014;41(2):256-64. doi: 10.3899/jrheum.130664; PMID: 24334642

9.       Kerr GS, Aujero M, Richards JS, Sayles H, Davis LA, Cannon GW, Caplan L, Michaud K, Mikuls TR. Associations of hydroxychloroquine use with lipid profiles in rheumatoid arthritis: pharmacologic implications. Arthritis Care Research (Hoboken). 2014 Apr 1; 66(11):1619-62; doi: 10.1002/acr.22341; PMID: 24692402

10.    Davis LA, Polk B, Mann A, Wolff RK, Kerr GS, Reimold AR, Cannon GW, Mikuls TR, Caplan L. Folic acid pathway single nucleotide polymorphisms associated with methotrexate significant adverse events in US veterans with rheumatoid arthritis. Clinical and Experimental Rheumatology 2014 May-Jun; 32(3):324-32; PMID: 24447348

11.    Davis LA, Whitfield E, Cannon GW, Wolff RK, Johnson DS, Reimold AR, Kerr GS, Richards JS, Mikuls TR, Caplan L. Association of rheumatoid arthritis susceptibility gene with lipid profiles in patients with rheumatoid arthritis. Rheumatology 2014 Jun; 53(6):1014-21; doi: 10.1093/rheumatology/ket472; PMID: 24489016

12. Dischinger HR, Cheng E, Davis LA, Caplan L. Practices and preferences for detecting chronic medication toxicity: a pilot cross-sectional survey of health care providers focusing on decision support systems. Journal of Evaluation in Clinical Practice 2014 Dec;20(6):1086-9. doi: 10.1111/jep.12192, PMID: 24903001

13.  Quinzanos I, Davis LA, Keniston A, Nash A, Yazdany J, Fransen R, Hirsh JM, Zell J. Application and feasibility of systemic lupus erythematosus reproductive health care quality indicators at a public urban rheumatology clinic. Lupus 2015 Feb;24(2):203-9. doi: 10.1177/0961203314552832; PMID: 2526707

14.    Quinzanos I, Luong PT, Bobba S, Richards JS, Majithia V, Davis LA, Caplan L. Validation of disease activity and functional status questionnaires in spondyloarthritis. Clinical and Experimental Rheumatology 2015 Mar-Apr;33(2):146-52. Epud 2015 Feb 9. PMID: 25664820

15.    Solow EB, You F, Thiele GM, Sokolove J, Robinson WH, Pruhs ZM, Michaud KD, Erickson AR, Sayles H, Kerr GS, Gaffo AL, Caplan L, Davis LA, Cannon GW, Reimold AM, Baker J, Schwab P, Anderson DR, Mikuls TR. Vascular calcifications on hand radiographs in rheumatoid arthritis and associations with autoantibodies, cardiovascular risk factors, and mortality. Rheumatology 2015 Apr 7. PMID: 25854268

16.    Dischinger H, Cheng E, Mann A, Grueber T, Hawk S, Davis LA, Prochazka AV, Hutt E, Caplan L. Decisional support to prevent adverse drug reaction of long latency: pilot randomized controlled intervention for glucocorticoid-induced diabetes. Journal of Evaluation in Clinical Practice 2015 Apr 7. doi: 10.1111/jep.12351; PMID: 25851076

17.    England BR, Sayles H, Michaud K, Cannon GS, Schwab P, Davis LA, Caplan L, Kerr GS, Reimold A, Solow E, Baker J, Mikuls T. Cause-specific mortality in US veteran men with rheumatoid arthritis. Arthritis Care & Research 2015 Jun 19. doi: 10.1002/acr.22642; PMID: 26097231

 

Published Abstracts (peer-reviewed):

1.       Davis L, Collier D, Caplan L. Gastric Antral Vascular Ectasia (GAVE) in Patients with Systemic Sclerosis (SSc): a Review of the Literature. [Abstract] Arthritis and Rheum 2007;56 (Suppl): S484. PMC Journal – In Process.

2.        Larson MM, Davis LA, Caplan L. Predictors of rheumatology clinic visit times [Abstract]. Arthritis Rheum 2009;60 (Suppl 10):S308. doi: 10.1002/art.27423

3.       Caplan L, McDonald JR, Kuhn J, Zeringue AL, Ranganathan P, Davis LA, Cunningham F, Eisen SA. Validation of administrative data to identify rheumatoid arthritis. [Abstract] Arthritis Rheum 2009;60 (Suppl10):S55. doi: 10.1002/art.25138; PMC Journal – In Process

4.       Davis LA, Cannon GW, Wolff RK, Haverhals LM, Mikuls TR, Reimold AM, Kerr GS, Richards JS, Johnson DS, Caplan L. Polymorphisms in the folate metabolism gene MTHFR (C677T and A1298C) are not associated with methotrexate adherence: findings from the Veteran’s Affairs Rheumatoid Arthritis (VARA) Registry [Abstract]. Arthritis Rheum 2010;62 (Suppl 10):S397. doi: 10.1002/art.28166

5.       Caplan L, Davis LA, Cannon GW, Pointer LM, Wolff RK, Mikuls TR, Reimold AM, Kerr GS, Richards JS, Johnson DS. Methotrexate use, MTHFR polymorphisms, and traditional risk factors in predicting cardiovascular events in rheumatoid arthritis (RA). VA Health Service Research & Development 28th National Meeting, Baltimore, MD, February 2011. doi:10.1136/ard.2011.151209.1; PMC Journal – In Process.

6.    Davis LA, Cannon GW, Reimold A, Kerr G, Mikuls T, Caplan L. Validation of Diagnostic and Procedural Codes for Identification of Incident Cardiovascular Disease in Subjects with Rheumatoid Arthritis [Abstract]. Arthritis Rheum 2011;63(Suppl10):S48. doi: 10.1002/art.33310

7.       Davis LA, Davis V, Trupin L, Yazdany J, Yelin E, Zell J. Increased Disease Activity Measure in Systemic Lupus Erythematosus Is Adversely Associated with Pregnancy and Pregnancy Outcomes [Abstract]. Arthritis Rheum 2011;63(Suppl10):S237-S238. doi: 10.1002/art.33310

8.       Davis LA, Pointer L, Wolff R, Reimold A, Kerr G, Mikuls T, Cannon GW, Caplan L. Association of Medications and Rheumatoid Arthritis Susceptibility Polymorphism with Lipid Profiles in Patients with Rheumatoid Arthritis [Abstract]. Arthritis Rheum 2011;63(Suppl10):S460-S461. doi: 10.1002/art.33310

9.       Davis LA, Ivan B, Mann A, Kerr G, Reimold AM, Cannon GW, Mikuls TR, Caplan L. Methotrexate adverse events in a cohort of US veterans with rheumatoid arthritis. [Oral Presentation] Arthritis Rheum 2012;64(Suppl 10):S1119. doi: 10.1002/art.37735

10.    Davis LA, Ivan B, Mann A, Wolff R, Kerr G, Reimold AM, Cannon GW, Mikuls TR, Caplan L. Folic acid pathway single nucleotide polymorphisms associated with methotrexate-related significant adverse events in US veterans with rheumatoid arthritis. [Oral Presentation] Arthritis Rheum 2012;64(Suppl 10):S1047-1048. doi: 10.1002/art.37735

11.    Kieffer NA, Kerr GS, Richards JS, Davis LA, Caplan L, Huang J, Cannon GW, Sayles H, Michaud K. Hydroxychloroquine has Lipid Lowering Effects in US Veterans with Rheumatoid Arthritis. [Oral Presentation] Arthritis Rheum 2012;64(Suppl 10):S1047. doi: 10.1002/art.37735

12.    Reimold AM, Caplan L, Clegg DO, Kerr GS, Chang E, Davis LA, Kaushik P, Majithia V, Richards JS, Taurog JD, Walsh J. Development of the PULSAR (Program to Understand the Longterm outcomes in SpondyloARthritis) Registry. [Poster] Arthritis Rheum 2012;64(Suppl 10):S939-S940. doi: 10.1002/art.37735

13.    Caplan L, Luong PT, Richards JS, Majithia V, Bobba S, Qaiyumi S, Davis LA. Validation of modified disease activity and functional status questionnaires in spondyloarthritis. European League Against Rheumatism June 12-15, 2013. Madrid, Spain.

14.    Davis LA, Goldstein B, Tran V, Keniston A, Yazdany J, Hirsh J, Storfa A, Zell J. Applying Choosing Wisely®: identifying inefficiencies of antinuclear antibody subserology testing in a safety net hospital system. American College of Rheumatology October 26-30, San Diego, CA (oral presentation 10/27/2013)

. Davis LA, Luong P, Bobba S, Dischinger H, Quinzanos I, Caplan L. Acceptability of various technology-based communication modalities in a rheumatology clinic. American College of Rheumatology October 26-30, San Diego, CA (poster presentation 10/29/2013)

16.    Hirsh J, Davis LA, Quinzanos I, Keniston A, Caplan L. Health literacy predicts discrepancies between traditional written rheumatoid arthritis patient assessments and verbally-administered assessments. American College of Rheumatology October 26-30, 2013 San Diego, CA (poster presentation 10/28/2013)

17.Young KA, Benissan-Messan D, Duryee MJ, Anderson DR, Davis LA, Caplan L, Sayles H, Hunter CD, Klasen LW, O’Dell JR, Mikuls TR, Thiele GM. Antibody to malondialdehyde-acetaldehyde adducts (MAA) is a biomarker of inflammation and is correlated with the disease activity in rheumatoid arthritis. American College of Rheumatology October 26-30, 2013 San Diego, CA

18.   Barron, G, Cheng E, Quinzanos I, Luong PT, Davis LA, Caplan L. Change in time-to-diagnosis of ankylosing spondylitis/ axial spondyloarthritis and psoriatic arthritis over the past five decades. Spondyloarthritis research and treatment network July 11-13, 2014, New York City, NY

19.   Quinzanos I, Luong PT, Richards S, Majithia V, Bobba S, Qaiyumi S, Davis LA, Caplan L. Validation of modified disease activity and functional status questionnaires in spondyloarthritis. Spondyloarthritis research and treatment network July 11-13, 2014, New York City, NY

20.   Quinzanos I, Luong PT, Richards JS, Majithia V, Bobba S, Qaiyumi S, Davis LA, Caplan L. Validation of modified disease activity and functional status questionnaires in spondyloarthritis. American College of Rheumatology 78nd Annual Scientific Meeting, Boston, MA. November 15-19, 2014.​

21.    Solow EB, Yu F, Sokolove J, Robinson WH, Pruhs ZM, Michaud KD, Erickson AR, Sayles H, Kerr GS, Gaffo AL, Caplan L, Davis LA, Cannon GW, Reimold AM, Schwab P, Mikuls TR. Vascular calcifications on hand and wrist radiographs are associated with cardiovascular risk factors, antigen-specific anti-citrullinated protein antibodies, and mortality in rheumatoid arthritis. American College of Rheumatology 78nd Annual Scientific Meeting, November 15-19, 2014.oral presentation Boston, MA.

22.  Bledsoe C, Davis L, Tran V, Keniston A, Caplan L, Quinzanos I, Hirsh J. Patients’ interpretations of rheumatoid arthritis model disease states in a safety-net rheumatology clinic. American College of Rheumatology 78nd Annual Scientific Meeting, November 15-19, 2014, Boston, MA

23.    Ruchlka P, Mikuls TR, Richards JS, Cannon GW, Kerr GS, Davis LA, Caplan L, Baker JF. Prevalence of cardiovascular disease in US veterans with rheumatoid arthritis and Hepatitis C infection. American College of Rheumatology 78nd Annual Scientific Meeting, November 15-19, 2014, Boston, MA.​